Extracellular vesicle-mediated crosstalk in tumor microenvironment dominates tumor fate
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Extracellular vesicles (EVs) are key communicators in the complex tumor microenvironment (TME). This review highlights their roles in shaping tumor fate and discusses challenges for clinical applications.
Area Of Science
- Oncology
- Cell Biology
- Biochemistry
Background
- The tumor microenvironment (TME) is a dynamic ecosystem of diverse cells.
- Intercellular communication within the TME is crucial for tumor progression.
- Extracellular vesicles (EVs) are significant mediators of this communication.
Purpose Of The Study
- To provide a comprehensive overview of the roles of EVs in the TME.
- To elucidate the mechanisms of intercellular communication mediated by EVs.
- To identify challenges and opportunities for clinical applications of EVs in cancer therapy.
Main Methods
- Literature review and synthesis of existing research on EVs in the TME.
- Analysis of EV cargo, donors, and recipient cell interactions.
- Evaluation of current and emerging therapeutic strategies involving EVs.
Main Results
- EVs play multifaceted roles in modulating the TME, influencing tumor cell behavior and immune responses.
- Focus has shifted from EV cargo to understanding the impact of EV-producing cells and target cells.
- Diverse mechanisms of EV-mediated intercellular dialog contribute to tumor fate.
Conclusions
- EVs are critical players in TME complexity and tumor progression.
- Further research into EV-mediated interactions is essential for therapeutic development.
- Harnessing EVs offers promising avenues for novel clinical treatment strategies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...